Sirius Regulatory Consulting EU
Sirius Regulatory Consulting EU is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
Actuate 1801: Phase 1/2 Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor, as a Single Agent and Combined with Chemotherapy, in Patients with Refractory Hematologic Malignancies or Solid Tumors
Sponsor Actuate Therapeutics Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Sirius Regulatory Consulting EU?
The 2026-10-09 snapshot links Sirius Regulatory Consulting EU to 1 distinct CTIS trials. Recorded services include Regulatory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Sirius Regulatory Consulting EU?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Sirius Regulatory Consulting EU conducted?
The linked trials record locations in 4 countries, including Belgium, Spain, France, Portugal. These are trial locations, not confirmed office locations or countries where Sirius Regulatory Consulting EU delivered services.
What can this page tell me about Sirius Regulatory Consulting EU's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sirius Regulatory Consulting EU. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Sirius Regulatory Consulting EU Limited